I think some more certainty on future profits - which could be secured funding and/or more concrete details of the project(s) so that people can make better judgement of likely profits. Our market cap is currently $20M so any annual profit of say $5Mpa or more with some more concrete evidence behind it should justify a re-rating.
The other catalyst I see is some certainty to rule out significant dilution via a capital raising.
EHR Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held